USPTO serial 79354142
LAVA THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 12, 2023
- Examiner
- PATEL, SAMIR RAMESH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LAVA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Antibodies for scientific and research use; libraries of antibodies and collections of antibodies for scientific and research use; proteins, enzymes, diagnostic reagents for scientific and research use, and chemical and biochemical preparations and substances for use in the manufacture of medicines | ACTIVE | — |
| 005 | Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders | ACTIVE | — |
| 042 | Bio-technology and scientific services, namely, research and development services relating to bio-technology and science in the field of antibodies, proteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, antibodies evolving services, protein evolving services and enzyme evolving services; biochemistry research services, namely, antibodies, protein and enzyme cataloging and antibodies, protein and enzyme library services; laboratory research and medical laboratory testing services relating to the production of antibodies, proteins and enzymes | ACTIVE | — |
| 044 | Providing medical information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks owned by Lava Therapeutics N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LAVA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 8, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 14, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 14, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 12, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 12, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 12, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 6, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 7, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 3, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 17, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 20, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 20, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 11, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 11, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 11, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 13, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |